86 related articles for article (PubMed ID: 21544409)
1. CD44 with variant exons 8-10 in colorectal tumors.
Goi T; Yamaguchi A; Takeuchi K; Nakagawa G; Yamashiro S; Furukawa K; Urano T; Shiku H
Int J Oncol; 1996 Apr; 8(4):657-62. PubMed ID: 21544409
[TBL] [Abstract][Full Text] [Related]
2. Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients.
Yamaguchi A; Urano T; Goi T; Saito M; Takeuchi K; Hirose K; Nakagawara G; Shiku H; Furukawa K
J Clin Oncol; 1996 Apr; 14(4):1122-7. PubMed ID: 8648366
[TBL] [Abstract][Full Text] [Related]
3. [Expression of variant CD44 in colorectal cancer and its relationship to liver metastasis].
Yamaguchi A
Nihon Geka Gakkai Zasshi; 1998 Jul; 99(7):409-14. PubMed ID: 9742519
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of liver metastasis formation by anti-CD44 variant exon 9 monoclonal antibody.
Seki K; Yamaguchi A; Goi T; Nakagawara G; Matsukawa S; Urano T; Furukawa K
Int J Oncol; 1997 Dec; 11(6):1257-61. PubMed ID: 21528332
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD44 variant exons 8-10 in gastric cancer.
Yamaguchi A; Saito M; Gio T; Iida A; Takeuchi K; Hirose K; Nakagawara G; Urano T; Furukawa K; Shiku H
Jpn J Cancer Res; 1995 Dec; 86(12):1166-71. PubMed ID: 8636005
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD44 variant exons 8-10 in colorectal cancer and its relationship to metastasis.
Takeuchi K; Yamaguchi A; Urano T; Goi T; Nakagawara G; Shiku H
Jpn J Cancer Res; 1995 Mar; 86(3):292-7. PubMed ID: 7538103
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of serum levels of CD44 variant exons 8-10 protein in colorectal cancer.
Yamaguchi A; Goi T; Taguchi S; Ohtaki N; Seki K; Hirose K; Nakagawara G; Urano T; Furukawa K
J Gastroenterol; 1998 Jun; 33(3):349-53. PubMed ID: 9658313
[TBL] [Abstract][Full Text] [Related]
8. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
Kopp R; Fichter M; Schalhorn G; Danescu J; Classen S
Int J Mol Med; 2009 Nov; 24(5):677-83. PubMed ID: 19787202
[TBL] [Abstract][Full Text] [Related]
9. CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis.
Sosulski A; Horn H; Zhang L; Coletti C; Vathipadiekal V; Castro CM; Birrer MJ; Nagano O; Saya H; Lage K; Donahoe PK; Pépin D
PLoS One; 2016; 11(6):e0156595. PubMed ID: 27253518
[TBL] [Abstract][Full Text] [Related]
10. Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma.
Ermak G; Jennings T; Robinson L; Ross JS; Figge J
Cancer Res; 1996 Mar; 56(5):1037-42. PubMed ID: 8640758
[TBL] [Abstract][Full Text] [Related]
11. Highly specific and sensitive detection of malignancy in urine samples from patients with urothelial cancer by CD44v8-10/CD44v10 competitive RT-PCR.
Miyake H; Okamoto I; Hara I; Gohji K; Yamanaka K; Arakawa S; Kamidono S; Saya H
Int J Cancer; 1998 Dec; 79(6):560-4. PubMed ID: 9842962
[TBL] [Abstract][Full Text] [Related]
12. Expression of variant CD44 containing variant exon v8-10 in gallbladder cancer.
Yamaguchi A; Zhang M; Goi T; Fujita T; Niimoto S; Katayama K; Hirose K
Oncol Rep; 2000; 7(3):541-4. PubMed ID: 10767365
[TBL] [Abstract][Full Text] [Related]
13. Molecular detection of cancer cells by competitive reverse transcription-polymerase chain reaction analysis of specific CD44 variant RNAs.
Okamoto I; Morisaki T; Sasaki J; Miyake H; Matsumoto M; Suga M; Ando M; Saya H
J Natl Cancer Inst; 1998 Feb; 90(4):307-15. PubMed ID: 9486817
[TBL] [Abstract][Full Text] [Related]
14. Over expression of CD44V8-10 in urinary exfoliated cells as an independent prognostic predictor in patients with urothelial cancer.
Miyake H; Eto H; Arakawa S; Kamidono S; Hara I
J Urol; 2002 Mar; 167(3):1282-7. PubMed ID: 11832714
[TBL] [Abstract][Full Text] [Related]
15. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
[TBL] [Abstract][Full Text] [Related]
16. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer.
Miyoshi T; Kondo K; Hino N; Uyama T; Monden Y
Clin Cancer Res; 1997 Aug; 3(8):1289-97. PubMed ID: 9815811
[TBL] [Abstract][Full Text] [Related]
17. A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps.
Heider KH; Hofmann M; Hors E; van den Berg F; Ponta H; Herrlich P; Pals ST
J Cell Biol; 1993 Jan; 120(1):227-33. PubMed ID: 8416989
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium.
Woerner SM; Givehchian M; Dürst M; Schneider A; Costa S; Melsheimer P; Lacroix J; Zöller M; Doeberitz MK
Clin Cancer Res; 1995 Oct; 1(10):1125-32. PubMed ID: 9815903
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of combined immunohistochemical detection of CD44v and sialyl LeX expression for colorectal cancer patients undergoing curative resection.
Yamaguchi A; Goi T; Seki K; Ohtaki N; Maehara M; Kobayashi T; Niimoto S; Katayama K; Hirose K; Nakagawara G; Matsukawa S
Oncology; 1998; 55(5):400-3. PubMed ID: 9732216
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells.
Fujita N; Yaegashi N; Ide Y; Sato S; Nakamura M; Ishiwata I; Yajima A
Cancer Res; 1994 Jul; 54(14):3922-8. PubMed ID: 7518345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
